Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients

Modern Pathology

Volumn 29, Issue 2, 2016, Pages 122-130

  Ko, Jennifer S ^a   Prieto, Victor G ^b   Elson, Paul J ^a   Vilain, Ricardo E ^c,d,e   Pulitzer, Melissa P ^f   Scolyer, Richard A ^c,d,e   Reynolds, Jordan P ^a   Piliang, Melissa P ^a   Ernstoff, Marc S ^a   Gastman, Brian R ^a   Billings, Steven D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d MELANOMA INSTITUTE AUSTRALIA   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SENTINEL LYMPH NODE METASTASIS; CARCINOMA, MERKEL CELL; CHEMISTRY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; SECONDARY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

TUMOR MARKER;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, MERKEL CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84956640162     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2015.109     Document Type: Article

References (34)

1. Moshiri AS, Nghiem P. Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw 2014;12:1255-1262.
2. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007;127:2100-2103.
3. Heath M, Jaimes N, Lemos B et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375-381.
4. Feng H, Shuda M, Chang Y et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
5. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10:878-889.
6. Sahi H, Savola S, Sihto H et al. RB1 gene in Merkel cell carcinoma: hypermethylation in all tumors and concurrent heterozygous deletions in the polyomavirus-negative subgroup. APMIS 2014;122:1157-1166.
7. Sihto H, Kukko H, Koljonen V et al. Merkel cell polyomavirus infection, large T angtigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 2011;17:4806-4813.
8. Miner AG, Patel RM, Wilson DA et al. Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod Pathol 2015;28:498-504.
9. Tseng J, Dhungel B, Mills JK et al. Merkel cell carcinoma: what makes a difference? Am J Surg 2015;209:342-346.
10. Schwartz JL, Griffith KA, Lowe L et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011;29:1036-1041.
11. Yiengpruksawan A, Coit DG, Thaler HT et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
12. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97-105.
13. Allen PJ, Bowne WB, Jaques DP et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300-2309.
14. Su LD, Lowe L, Bradford CR et al. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002;46:661-666.
15. Allen PJ, Busam K, Hill AD et al. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001;92:1650-1655.
16. Stakaitytė G, Wood JJ, Knight LM et al. Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus. Cancers (Basel) 2014;6:1267-1297.
17. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011;331:1565-1570.
18. Tseng J, Dhungel B, Mills JK et al. Merkel cell carcinoma: what makes a difference? Am J Surg 2015;209:342-346.
19. Tsuda H. Histological examination of sentinel lymph nodes: significance of macrometastasis, micrometastasis, and isolated tumor cells. Breast Cancer 2015;22:221-229.
20. Balch CM, Gershenwald JE, Soong SJ et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010;28:2452-2459.
21. Murali R, DeSilva C, McCarthy SW et al. Sentinel lymph nodes containing very small <0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Ann Surg Oncol 2012;19:1089-1099.
22. Morton DL, Thompson JF, Cochran AJ et al. MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370:599-609.
23. Giuliano AE, Hawes D, Ballman KV et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 2011;306:385-393.
24. Gatzemeier W, Mann GB. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)-ACOSOG Z0011 results and beyond. Breast 2013;22:211-216.
25. Sadeghi R, Adinehpoor Z, Maleki M et al. Prognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studies. Biomed Res Int 2014;2014:489536.
26. Grotz TE, Joseph RW, Pockaj BA et al. Negative sentinel lymph node biopsy in merkel cell carcinoma is associated with a low risk of same-nodal-basin recurrences. Ann Surg Oncol 2015;22:4060-4066.
27. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol 2010;17:1471-1474.
28. Shibayama Y, Imafuku S, Takahashi A et al. Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases. Int J Clin Oncol 2015;20:188-193.
29. Gupta SG, Wang LC, Penas PF et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685-690.
30. Lemos BD, Storer BE, Iyer JG et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751-761.
31. Mehrany K, Otley CC, Weenig RH et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2010;28:113-117.
32. Maza S, Trefzer U, Hofmann M et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging 2006;33:433-440.
33. Fields RC, Busam KJ, Chou JF et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for Markel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011;18:2529-253.
34. Warner RE, Quinn MJ, Hruby G et al. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008;15:2509-2518.